Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.

Treatment with treprostinil led to significant and sustained improvements in children with PH associated with lung disease, ...

The analysis revealed dozens of genes with abnormal expression in cells from people with idiopathic PAH, and the researchers ...

“This study provides comprehensive preclinical evidence that the novel PDE5 inhibitor CPD1 is a potent therapeutic candidate ...

Pulmonary hypertension (PH) is caused by high blood pressure in the lungs, which is caused by narrowed and thickened pulmonary arteries. Because of the added effort needed to pump blood through the ...

World Pulmonary Hypertension Day 2026 highlights hope through clinical trials for the global disease community.

Corvista Health and Mayo Clinic will study whether Corvista-PH can improve pulmonary hypertension diagnosis and referrals.

Irregular heart rhythms in people with pulmonary arterial hypertension are linked to a greater risk of poor outcomes, a U.S.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Babies with bronchopulmonary dysplasia (BPD), a lung disorder ...

The activity of a gene called RUNX1 may serve as a biological marker of processes that can lead to right heart failure in pulmonary arterial hypertension (PAH), a study reports. Progressive decline of ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google You wake up exhausted. A long night of chest pains and other ...